ClinVar Miner

Variants studied for GATA2 deficiency with susceptibility to MDS/AML

Included ClinVar conditions (4):
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
26 9 169 35 4 238

Gene and significance breakdown #

Total genes and gene combinations: 1
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign benign total
GATA2 26 9 169 35 4 238

Submitter and significance breakdown #

Total submitters: 10
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance likely benign benign total
Invitae 10 3 145 12 3 173
Illumina Clinical Services Laboratory,Illumina 0 0 24 22 1 47
OMIM 15 0 0 0 0 15
Mendelics 1 3 1 1 0 6
Fulgent Genetics,Fulgent Genetics 0 0 6 0 0 6
UCLA Clinical Genomics Center, UCLA 1 1 0 0 0 2
Johns Hopkins Genomics,Johns Hopkins University 0 0 2 0 0 2
Undiagnosed Diseases Network,NIH 1 0 0 0 0 1
Department of Immunology,University Hospital Southampton NHSFT 0 1 0 0 0 1
Molecular Diagnostics Laboratory, M Health: University of Minnesota 0 1 0 0 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.